Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer

Journal of radiation research

Volumn 54, Issue 4, 2013, Pages 679-683

  Nakata, Kensei ^a   Sakata, Koh Ichi ^a   Someya, Masanori ^a   Miura, Katsutoshi ^a   Hayashi, Junichi ^a   Hori, Masakazu ^a   Takagi, Masaru ^a   Himi, Tetsuo ^a   Kondo, Atsushi ^a   Hareyama, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

chemoradiotherapy; head and neck cancer; Phase I study; S 1

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DRUG COMBINATION; OTERACIL; S 1 (COMBINATION); TEGAFUR;

AGED; ANOREXIA; CARCINOMA, SQUAMOUS CELL; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PROCEDURES; RHABDOMYOLYSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANOREXIA; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; OXONIC ACID; RHABDOMYOLYSIS; TEGAFUR; TREATMENT OUTCOME;

EID: 84893161948     PISSN: None     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs133     Document Type: Article

References (0)